Showing results (11-20 of 331) with videos related to
Sort By:
Pageof 34
Current Treatment Options in Oncology|March 23, 2015
Treatment of NRAS-mutant melanomaDouglas B Johnson, Igor PuzanovExpert Review of Anticancer Therapy|December 10, 2025
Overcoming toxicity challenges in immune checkpoint inhibitor treatment of high-risk metastatic cancersRishitha Nalabothu, Douglas B JohnsonJournal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
BRAFV600E-mutant melanoma presenting with cardiac involvementDouglas B Johnson, Jeffrey A SosmanThe Oncologist|January 20, 2025
Steroid-refractory immune mediated hepatitis managed with budesonide in patients with metastatic melanoma: proof of concept and literature reviewRoma A Kankaria, Douglas B JohnsonExperimental Hematology|May 1, 2012
How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation?Douglas B Johnson, Bipin N SavaniClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
Biomarkers for Immunotherapy Toxicity: Are Cytokines the Answer?Douglas B Johnson, Justin M BalkoAmerican Journal of Clinical Dermatology|September 2, 2017
Combinatorial Therapies in Melanoma: MAPK Inhibitors and BeyondAlice Y Zhou, Douglas B JohnsonMelanoma Management|September 8, 2018
Advances in the development of intralesional therapies for melanomaDaniel Y Wang, Douglas B JohnsonDrugs|October 1, 2025
Long-Term Toxicities of Immune Checkpoint InhibitorsPreethy E Abraham, Douglas B JohnsonJAMA Oncology|July 17, 2015
Therapeutic Advances and Treatment Options in Metastatic MelanomaDouglas B Johnson, Jeffrey A SosmanPageof 34